Doxiciclina util en penfigoide ampolloso

CONFERENCE COVERAGE 

For bullous pemphigoid, doxycycline noninferior to prednisolone, but safer

Publish date: March 4, 2017

By: 

Michele G. Sullivan 

 

Dermatology News 

 

 

 

Key clinical point: While not as effective as prednisolone, doxycycline was significantly safer for elderly patients with bullous pemphigoid.

Major finding: At 6 weeks, treatment succeeded in 74% of the doxycycline group and 91% of the prednisolone group; severe adverse events occurred in 18% and 36%, respectively.

Data source: The BLISTER trial randomized 253 patients.

Disclosures: The trial was run in collaboration with the Nottingham Clinical Trials Unit, the UK Dermatology Clinical Trials Network, and the Medical Research Council Clinical Trials Unit. Dr. Harman had no financial disclosures.

Benjamin Hidalgo-Matlock

Skin Care Physicians of Costa Rica

4000-1054

2208-8206

Please excuse the shortness of this message, as it has been sent from a mobile device.